Article
Thermolabile methylenetetrahydrofolate reductase in coronary artery disease.
Circulation - 21 Oct 1997
Kluijtmans L A, Kastelein J J, Lindemans J, Boers G H, Heil S G, Bruschke A V, Jukema J W, van den Heuvel L P, Trijbels F J, Boerma G J, Verheugt F W, Willems F, Blom H J
Abstract excerpt
BACKGROUND: Hyperhomocysteinemia, an independent and graded risk factor for coronary artery disease (CAD), may result from both environmental and hereditary factors. Methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of methylenetetrahydrofolate to methyltetrahydrofolate, the methyl donor in the remethylation of homocysteine to methionine. A 677C-->T mutation in the MTHFR gene has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
